AXDX
Accelerate Diagnostics IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
859,920
P/E Ratio
—
EPS
$-2.15
Beta
0.22
52W High
$0.64
52W Low
$0.01
50-Day MA
$0.53
200-Day MA
$1.25
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
-0.55
About Accelerate Diagnostics Inc
Accelerate Diagnostics, Inc., an in vitro diagnostic company, offers solutions for diagnosing serious infections in the United States, Europe, and the Middle East. The company is headquartered in Tucson, Arizona.
Fundamentals
| Revenue (TTM) | $11.70M |
| Gross Profit (TTM) | $2.70M |
| EBITDA | $-31.89M |
| Operating Margin | -281.70% |
| Return on Equity | 0.00% |
| Return on Assets | -73.70% |
| Revenue/Share (TTM) | $0.50 |
| Book Value | $-2.23 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 0.07 |
| EV/Revenue | 4.31 |
| EV/EBITDA | -1.10 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -7.00% |
| Shares Outstanding | $25.29M |
| Float | $13.46M |
| % Insiders | 38.31% |
| % Institutions | 17.92% |
Data last updated: 4/7/2026